Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mammalian deoxyribonucleoside kinases

E S Arnér1, S Eriksson

  • 1Medical Nobel Institute for Biochemistry, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Sweden.

Pharmacology & Therapeutics
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of thioredoxin and thioredoxin reductase.

Current protocols in toxicology·2010
Same author

Reactive oxygen species, antioxidants, and the mammalian thioredoxin system.

Free radical biology & medicine·2001
Same author

Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex.

Free radical biology & medicine·2001
Same author

The core promoter of human thioredoxin reductase 1: cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AU-rich element-regulated gene.

The Journal of biological chemistry·2001
Same author

Physiological functions of thioredoxin and thioredoxin reductase.

European journal of biochemistry·2000
Same author

Truncated thioredoxin is a mitogenic cytokine for resting human peripheral blood mononuclear cells and is present in human plasma.

The Journal of biological chemistry·2000

Mammalian deoxyribonucleoside kinases are crucial for DNA synthesis and activating cancer drugs. This review details their roles, structure, and therapeutic significance.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Mammalian deoxyribonucleoside kinases (deoxycytidine kinase, thymidine kinase 1 and 2, deoxyguanosine kinase) are key enzymes.
  • These enzymes phosphorylate deoxyribonucleosides, providing an alternative to de novo DNA precursor synthesis.
  • Their activity is vital for activating nucleoside analogues used in chemotherapy.

Purpose of the Study:

  • To review recent characterizations of deoxyribonucleoside kinases regarding structure, substrate specificity, and expression patterns.
  • To discuss the physiological metabolic roles of these anabolic enzymes in relation to catabolic pathways.
  • To explore the significance of this knowledge for developing therapeutic protocols and selecting animal models.

Main Methods:

Related Experiment Videos

  • Literature review of recent research on mammalian deoxyribonucleoside kinases.
  • Analysis of enzyme structure, substrate specificity, and expression patterns.
  • Discussion of physiological roles, including anabolic and catabolic pathways.

    • Main Results:

    • Recent studies have thoroughly characterized deoxyribonucleoside kinases.
    • The review discusses their structure, substrate specificity, and expression.
    • Physiological roles and therapeutic implications are explored.

    Conclusions:

    • Understanding deoxyribonucleoside kinases is essential for cancer therapy development.
    • Knowledge of these enzymes aids in selecting appropriate animal models for drug testing.
    • Alternative phosphorylation pathways, like those involving 5'-nucleotidase, are also considered.